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Abstract
The hypoxic and acidic microenvironments in tumors are strongly associated with malignant progression and metastasis,
and have thus become a central issue in tumor physiology and cancer treatment. Despite this, the molecular links between
acidic pH- and hypoxia-mediated cell invasion/metastasis remain mostly unresolved. One of the mechanisms that tumor
cells use for tissue invasion is the generation of invadopodia, which are actin-rich invasive plasma membrane protrusions
that degrade the extracellular matrix. Here, we show that hypoxia stimulates the formation of invadopodia as well as the
invasive ability of cancer cells. Inhibition or shRNA-based depletion of the Na
+/H
+ exchanger NHE-1, along with intracellular
pH monitoring by live-cell imaging, revealed that invadopodia formation is associated with alterations in cellular pH
homeostasis, an event that involves activation of the Na
+/H
+ exchange rate by NHE-1. Further characterization indicates that
hypoxia triggered the activation of the p90 ribosomal S6 kinase (p90 RSK), which resulted in invadopodia formation and
site-specific phosphorylation and activation of NHE-1. This study reveals an unsuspected role of p90RSK in tumor cell
invasion and establishes p90RS kinase as a link between hypoxia and the acidic microenvironment of tumors.
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Introduction
Recent research indicates that important metabolic changes
occur within the tumor microenvironment and that these changes
correlate with tumor progression and metastasis [1]. Hypoxia has
been recognized as an important feature of solid tumors and arises
presumably because of an increased metabolic demand associated
with defective vascularization [2]. Hypoxia plays a critical role in
various cellular events, including cell proliferation and metabo-
lism, as well as tumor invasion and metastasis [3]. In fact, the
hypoxic microenvironment of solid tumors selects for survival of
aggressive, highly invasive cells that have the propensity to
metastasize [4,5]. Hypoxia also triggers an increase in the rate of
glycolysis. This increase has been largely attributed to the
transcriptional upregulation of the glucose transporters GLUT1
and GLUT4, and enzymes of the glycolytic pathway triggered by
the hypoxia-inducible factor HIF-1 [6]. Lactate production during
anaerobic glycolysis generates an excess of protons that are
extruded by ion transporters and pumps resulting in acidosis of
tumor microenvironment [7]. pH measurement in cancer cell lines
and within tumors has revealed that the extracellular pH (pHe)o f
malignant tumor microenvironment varies from 6.2 to 6.9,
whereas pHe in healthy tissues is 7.2 to 7.5 [8,9,10,11]. In
contrast, intracellular pH (pHi) of cancer cells is more alkaline than
in normal cells. Analogous to hypoxia, various studies have shown
that alterations in pHe and pHi modify the phenotype of tumor
cells. Acidic conditions, similar to those prevailing in many tumors,
have been shown to increase transcription of VEGF [12], of IL-8
[13,14], and to promote extracellular release/or expression/or
activity of key proteases such as cathepsin B and matrix
metalloproteinases (MMPs) [15]. Acidosis also amplifies in vitro
cell invasion and in vivo metastasis [14,16,17], events inhibited by
the reversal of tumor acidosis by NaHCO3 administration [18].
Despite the physiological and clinical significance of the
relationship between pH- and hypoxia-associated cell invasion
and metastasis, this question remains largely unresolved.
Sodium-proton exchangers (NHEs), sodium-dependent and -
independent HCO3
2/Cl
2 exchangers, H
+/lactate co-transporters
and V-ATPase are mediators of pH homeostasis in healthy as well
as cancer cells. Mammalian Na
+/H
+-exchangers (NHEs) are
members of a family of nine related gene products (NHE1-9).
They are integral membrane proteins that share up to 70% amino
acid identity. The plasma membrane-type NHEs (NHE1-5)
primarily catalyze the electroneutral exchange of one extracellular
Na
+ for one cytosolic H
+. NHE-1 has an ubiquitous tissue
distribution, whereas NHE2-5 have a more restricted distribution.
Among these exchangers, NHE-1 is considered a main regulator
of pHi in cancer cells. NHE-1 activity is regulated by pHi and
oncogenic transformation [19,20]. NHE-1 expression and activity
have been shown to enhance the invasive capability of tumor cells
through increased release and activity of MMPs and cathepsins
[16,17,21], changes in gene expression, and regulation of the actin
cytoskeleton [22,23]. NHE-1, in breast cancer cells stimulated with
EGF, has also been located at invadopodia protrusion sites where
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extracellular microenvironment, resulting in focal ECM degrada-
tion [24]. In addition to its well-known N-terminal H
+ sensor and
ion translocation function, an increasing number of studies have
indicated that the C-terminal cytoplasmic tail of NHE-1 is
implicated in the regulation of various cellular processes [25].
For instance, NHE-1 interacts with actin-binding proteins and that
results in promotion of cytoskeletal reorganization and cell
migration. In addition, phosphorylation of serine residues in the
C-terminal domain, by serine/threonine kinases, may increase
NHE-1 activity or promote downstream signaling events associ-
ated with NHE-1 activation. Several protein kinases have been
proposed to regulate NHE-1 activity, including NIK, p90RSK
and ROCK1. Among these, p90RSK has been reported to
phosphorylate Ser
703 in the C-terminal domain of NHE-1,
resulting in an increased rate of Na
+/H
+ exchange in response
to serum [26]. Whereas the role of p90RSK in the activation of
NHE-1 is beginning to be understood, its implication in cell
migration and invasion need to be further evaluated.
Metastatic tumor cells that actively migrate and invade
surrounding tissues rely on cell membrane protrusions named
invadopodia to degrade the extracellular matrix (ECM) barrier. In
vitro and in vivo studies on breast cancer and melanoma progression
have revealed a correlation between invadopodia formation and
the potential of cell invasiveness [27,28]. The basic molecular
components involved in invadopodia formation and function are
getting better defined. Invadopodia formation depends on a series
of complex interactions between signal transduction molecules
including members of serine/threonine and tyrosine kinase
families, various classes of integrins, which provide attachment
to the substratum, as well as cytoskeleton components and
regulatory proteins such as N-WASP, Arp2/3, Tks5, F-actin and
cortactin. Soluble and membrane-bound proteases, mostly me-
talloproteinases, are enriched at invadopodia sites and that
correlates with the invasive potential of cancer cells [29,30].
Invadopodia formation has been shown to be induced by few
stimuli, including integrin engagement by ECM components, EGF
and LPA [31,32,33]. Therefore, despite intensive research on
invadopodia biology, little is known about specific inducers/
enhancers during tumor progression.
In the present study, we showed that hypoxia stimulated
invadopodia formation and cell invasion in cancer cells. Using the
invasive fibrosarcoma cell line HT-1080, we observed that
invadopodia formation was also associated with variations in
pHi, an observation that was related to activation of NHE-1. We
also present evidence for a hitherto unsuspected role of p90RSK
that is related to its capacity to phosphorylate and activate NHE1
under hypoxic conditions and, consequently, to trigger an increase
in invadopodia formation. Our results provide new insights into
the relationship between hypoxia and the acidic microenviron-
ment during the metastatic process.
Results
Hypoxia increases NHE-1 activity in HT-1080 cells
Cytoplasmic pH (pHi) as well as extracellular pH (pHe) are
tightly regulated, in part through Na
+/H
+ exchangers, including
NHE-1, which is ubiquitously expressed in eukaryotic cells. A
recent report has indicated that exposure of arterial myocytes to
chronic hypoxia resulted in an alkaline shift in pHi and increased
NHE-1 activity [34]. To establish whether short-term hypoxia
influenced pHi homeostasis and NHE-1 activity in HT-1080 cells,
they were exposed to normoxia or hypoxia (1% O2) for 4 h in a
bicarbonate-free solution, a condition that prevents contributions
from the Cl
2/HCO3
2 exchangers [20]. Under these conditions,
steady-state pHi was significantly increased in HT-1080 cells
exposed to 1% O2 for 4 h (7.2160. 03) as compared to cells
cultured under normoxic conditions (6.9360.06) (Figure 1A).
Similar findings were observed for the 8 h time-point (data not
shown). Inhibition of NHE-1 by treating the cells with the NHE-1
inhibitor EIPA or by knocking down NHE-1 using shRNA
strongly reduced the increase in pHi due to hypoxia (Figure 1A). In
addition, NHE-1 activity (determined by the Na
+/H
+-exchange
rate (dpHi/dt)) was increased 2-fold in HT-1080 cells cultured
under hypoxic conditions when compared to cells exposed to
normoxia (Figure 1B). The increase in NHE-1 activity was further
augmented in cells overexpressing NHE-1 (Figure 1C). In contrast,
knocking down NHE-1 fully blocked the hypoxia-mediated
increase in pHi recovery and Na
+/H
+ exchange rate (Figure 1D),
an effect that was reversed by rescue experiments involving
reintroduction of NHE-1 into knockdown cells (Figure 1E). We
further investigated whether the findings observed in HT-1080
cells applied to other cancer cell lines. Hypoxia increased NHE-1
activity in human breast cancer cell line MDA-MB-231 and mouse
B16 melanoma cells (Figure S1A–1B). Taken together, these
results indicated that hypoxia altered pHi homeostasis in a variety
of neoplastic cells, a condition that involved the Na
+/H
+
exchanger NHE-1.
Hypoxia-induced NHE-1 activity occurs in an HIF-1-
independent manner
Chronic exposure of arterial myocytes to hypoxia has been
shown to result in an increased in NHE-1 expression and activity,
which was proposed to be due to HIF-1-dependent-transcriptional
activation of the exchanger [34]. To investigate whether our
observations of an upregulation of NHE-1 activity observed after a
4 h exposure to hypoxia could be explained by a HIF-1-dependent
increase in NHE-1 expression, we quantified NHE-1 mRNA and
protein levels in HT-1080 cells incubated for various periods of
time under hypoxic conditions. Although results showed a
significant increase in NHE-1 mRNA and protein expression
after 16 h exposure to a low oxygen concentration, there were no
significant changes after 4 h and 10 h of exposure (Figure 2A–2B),
which correspond to times where we observed an increase in
NHE-1 activity (Figure 1A–1B and data not shown). These results
suggested a lack of involvement of either HIF-1 and/or variations
in NHE-1 concentrations in the increase in NHE-1 activity in
response to short-term exposure to hypoxia. This interpretation
was further supported by experiments demonstrating that the
increase in the rate of Na
+/H
+ exchange was not affected in HIF-1
knockdown cells exposed to low oxygen concentrations for 4 h
(Figure 2C). Altogether, these data indicated that the observed
increase in NHE-1 activity was not due to HIF-1-dependent or -
independent modulation of NHE-1 expression.
NHE-1 is required for hypoxia-induced invadopodia
formation and function
To evaluate the functional relevance of the increase in NHE-1
activity under hypoxia, we first examined whether acidic pHe
influenced the capacity of the cells to degrade the extracellular
matrix. HT-1080 cells were seeded onto coverslips coated with
fluorescent gelatin in medium at pH 7.4 or 6.6 and the cells were
allowed to degrade the gelatin matrix under normoxic or hypoxic
conditions for 10 h. Cells were then fixed, stained with Texas Red-
phalloidin (actin) and DAPI (nucleus), and the percentage of
ECM-degrading cells was determined by fluorescence microscopy.
Results showed that the ability of the cells to degrade fluorescent
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PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28851Figure 1. Hypoxia increases NHE-1 activity in HT-1080 cells. (A) Control (untransfected) HT-1080 cells incubated in the presence or absence of
the NHE-1 inhibitor, EIPA (25 mM), or cells transfected with scrambled (control) shRNA, or NHE-1 shRNA, were incubated for 4 h under normoxic or
hypoxic conditions. Basal intracellular pH (pHi) was measured using BCECF (n=300 cells). Immunoblot showing knock down of NHE-1 expression in
NHE-1 shRNA transfected cells. Actin was used as a loading control. (B–D) Representative traces showing pHi recovery after ammonium chloride-
prepulse-induced acidification in HT-1080 cells cultured under normoxic or hypoxic conditions with associated bar graph showing Na
+/H
+ exchange
rates (n=300 cells per condition), for (B) untransfected cells, (C) cells transfected with p-NHE-1, or (D) cells transfected with control shRNA or NHE-1
shRNA. (E) Rescue experiments were performed by transfection of NHE-1 shRNA-transfected cells with pNHE-1. Na
+/H
+ exchange rates were
measured in cells exposed to normoxic or hypoxic conditions. Columns represent the mean 6 SEM indicated by the horizontal bars. The asterisks
correspond to, * p,0.01; ** p,0.001; *** p,0.0001.
doi:10.1371/journal.pone.0028851.g001
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medium and that this was further augmented by exposure of the
cells to hypoxia (Figure 3A). The presence of actin clusters at the
basal plasma membrane that colocalized with areas of ECM
degradation indicated that such cell degradation process was
induced by invadopodia (Figure 3B). Transient overexpression of
NHE-1 significantly increased the percentage of invadopodia
producing cells incubated under normoxic or hypoxic conditions
(Figure 3C). In contrast, knockdown of NHE-1 abrogated the
capacity of the cells to produce more invadopodia under hypoxic
conditions (Figure 3D). Similar results were obtained when NHE-1
activity was inhibited following cell treatment with the NHE-1-
selective inhibitors EIPA or zoniporide in HT-1080, MDA-MB-
283, and B16 cells (Figures S1C-S1D, S2A). Furthermore,
overexpression of NHE-1 induced an increase in the number of
invadopodia formed per cell, identified by clusters of actin and
cortactin, two bona fide markers of invadopodia [35], as well as an
increase in the areas of ECM degradation per cell (Figures 3E–3F).
In contrast, depletion of NHE-1 by shRNA abolished both
hypoxia-induced invadopodia formation and ECM degradation
(Figures 3G–3H). Taken together, these results indicated that
NHE-1 was required for hypoxia-induced invadopodia formation
and function in cancer cells.
NHE-1 is required for hypoxia-induced cell invasion
We next investigated the contribution of the NHE-1 exchanger
to cell invasion using a 3D cell invasion assay. This assay is known
to measure both the amoeboid- (protease-independent) and
mesenchymal-like (protease-dependent) modes of cell dissemina-
tion [36]. Cells transfected with NHE-1 or control shRNA were
seeded on top of fibrillar type I collagen gels and allowed to
migrate under normoxia and hypoxia for 24 h. Cells were then
stained with calcein-AM and cells that had invaded collagen gels
were imaged and quantitated at each 5 mm layer within the gel
using confocal microscopy. Results showed that knocking down
NHE-1 significantly decreased the capacity of the cells to invade
deeply into the collagen gels and fully blocked their ability to
respond to hypoxia-induced enhanced migration (Figure 4A–4B).
Therefore, as in the case of the invadopodia assays, our results
indicated that NHE-1 was essential for hypoxia-induced cell
invasion through 3D-collagen matrices. They also indicated that,
under normoxia, NHE-1 was not involved in invadopodia
formation but it was required for cell invasion, possibly due to
its role as a plasma membrane anchor for cortical actin filaments
at the leading edge of the lamellipodia [37,38], leading to an
amoeboid mode of cell migration [39].
Activation of p90RSK by hypoxia results in NHE-1
activation and invadopodia generation
Data shown above revealed that the increase in NHE-1 activity
was not due to a HIF-1-dependent or -independent modulation of
NHE-1 expression, suggesting the involvement of post-transla-
tional mechanisms. NHE-1 exchange activity can be regulated by
phosphorylation of its cytoplasmic tail [25]. Among the kinases
known to activate NHE-1, the serine kinase p90RSK has been
shown to increase NHE-1 activity by phosphorylation of a key
serine
703 residue located in the cytoplasmic tail of the exchanger
which serves as a docking site for the 14-3-3 adaptor protein [26].
To investigate whether p90RSK was involved in hypoxia-induced
NHE-1 activation, we first examined the state of phosphorylation
of p90RSK in HT-1080 cells under hypoxic conditions. Time-
course studies revealed that p90RSK phosphorylation was sharply
increased 30 min and 45 min following exposure of the cells to
hypoxia, as compared to normoxia (Figure 5A). Hypoxia-induced
phosphorylation was almost completely blocked by PD98059
suggesting the involvement of the MAPK pathway in p90RSK
activation. In a second set of experiments, an antibody directed
against the 14-3-3 binding motif was used to reveal the NHE-1
Ser
703 phosphorylation site [40]. The levels of NHE-1 Ser
703
phosphorylation coincided with hypoxic activation of p90RSK,
suggesting a role for this kinase in NHE-1 activation (Figure 5A).
To further assess the involvement of p90RSK in hypoxia-induced
Figure 2. Hypoxia-induced NHE-1 activity occurs in a HIF-1-
independent manner. HT-1080 cells were exposed to normoxic or
hypoxic conditions for the indicated times. (A) NHE-1 mRNA expression
measured by RT-PCR (n=3). (B) Representative immunoblot showing
NHE-1 expression in cell lysates (n=3). Actin was used as a loading
control. (C) Na
+/H
+ exchange rate in HT-1080 cells transfected with HIF-
1a shRNA or control (scrambled) shRNA and exposed to 21% O2 or 1%
O2 for 4 h. Immunoblot showing HIF-1a knock down in cell lysates.
Nup62 was used as a loading control. NS: not significant. Columns
represent the mean 6 SEM indicated by the horizontal bars. The
asterisks correspond to, *** p,0.0001.
doi:10.1371/journal.pone.0028851.g002
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or the absence of the selective p90RSK inhibitor BI-D1870 or,
were transfected with a dominant negative form of p90RSK [41]
prior to exposure to hypoxic conditions. Results showed that
hypoxia-induced NHE-1 activity was inhibited by 60% and 40%
in cells treated with BI-D1870 or in cells expressing the dominant
negative form of p90RSK, respectively (Figure 5B–5C). The need
for NHE-1 Ser
703 phosphorylation in hypoxia-induced NHE-1
activation was investigated in HT-1080 cells transfected with a
non-phophorylatable mutant form (S703A) of NHE-1. Results
Figure 3. Hypoxia-induced NHE-1 activity promotes invadopodia formation. HT-1080 cells exposed to normoxic (empty bars) or hypoxic
(filled bars) conditions were cultured on a layer of Oregon Green-labeled gelatin for 10 h and stained with Texas Red-phalloidin (actin) and DAPI
(nucleus). The percentage of cells that formed invadopodia was determined by fluorescence microscopy. (A) Percentage of invadopodia-forming cells
cultured in medium at pH 7.4 or 6.6 (n=3). (B) Representative confocal microscopy image showing actin staining at sites of Oregon Green-gelatin
degradation. Boxed area is enlarged in the corresponding lower panel. The merged image also shows a reconstruction of the x-z profile (inset)
through the plane indicated by the solid line within the image. (C–D) Percentage of invadopodia-forming HT-1080 cells (C) transfected with pNHE-1
or an empty vector (pECE) (n=3) or, (D) transfected with control (scrambled) or NHE-1 shRNA (n=3–4). Number of invadopodia formed per cell
(actin/cortactin clusters), and corresponding area of degradation per cell, quantified from 20 random fields per experiment, in cells (E–F) transfected
with pNHE-1 or an empty control vector (pECE) (n=2–3) or, (G–H) transfected with NHE-1 shRNA or control (scrambled) shRNA (n=2–3). Columns
represent the mean 6 SEM indicated by the horizontal bars. The asterisks correspond to, * p,0.01; ** p,0.001; *** p,0.0001.
doi:10.1371/journal.pone.0028851.g003
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poorly to hypoxia, in contrast to control cells harboring wild type
NHE-1 (Figure 5D) despite similar levels of overexpression (data
not shown). Taken together, these results strongly suggested that
phosphorylation of NHE-1 Ser
703 by p90RSK was part of the
essential events involved in the activation of NHE-1 under
hypoxia.
To evaluate the role of p90RSK in cell invasion promoted by
hypoxia, we performed invadopodia formation assays in the
presence or absence of inhibitors of p90RSK. Treatment of HT-
1080 cells with BI-D1870 led to a dose-dependent decrease in
invadopodia formation and function (area of degradation per cell)
(Figure 6A–6B). A similar inhibition was observed in HT-1080
cells transfected with the dominant negative form of the kinase
(Figure 6C). In addition, overexpression of the S703A NHE-1
mutant resulted in strong inhibition of HT-1080 ability to enhance
invadopodia production in response to hypoxia as compared to
cells transfected with wild type NHE-1 (Figure 6D). These results
suggested that phosphorylation of NHE-1 by p90RSK was
required, at least in part, for hypoxia-induced invadopodia
formation and functions.
NHE-1 is located at sites of invadopodia formation in
hypoxic cells
We next examined whether NHE-1 was localized at invadopo-
dia sites using antibodies that recognize the C-terminal portion of
human NHE-1. Results showed that increased amounts of NHE-1
were present in numerous discrete puncta of fluorescence at the
ventral surface of hypoxic HT-1080 cells (basal plasma membrane
stained with DiI) that corresponded to typical invadopodia
locations (Figure 7A–7B). Such increases appeared to be
independent of NHE-1 phosphorylation by p90RSK because cells
overexpressing the NHE-1 S703A mutant showed similar
augmentations in NHE-1 localization at the basal plasma
membrane in response to hypoxia compared to cells overexpress-
ing the wild-type gene (Figure 7B). To define whether the observed
areas of NHE-1 fluorescence at the basal plasma membrane
corresponded to invadopodia formation sites, antibodies directed
against cortactin were used. Results showed that ventral NHE-1
puncta co-localized with cortactin clusters under hypoxic condi-
tions, suggesting NHE-1 localization to invadopodia structures in
hypoxic cells (Figure 7C).
Discussion
The tumor hypoxic and acidic microenvironment exerts
profound influence on cancer cell invasion and metastasis and
these characteristics are considered as important targets for the
development of new anti-cancer therapies. Despite numerous
studies in this field, the fundamental relationship between pH- and
hypoxia-induced cell invasion is still poorly understood. Here, we
showed that hypoxia promoted NHE-1 activity and its relocation
to the basal plasma membrane where NHE-1-induced extracel-
lular acidification leads to invadopodia production and cell
invasion. We further provided evidence that hypoxia modulated
NHE-1 activity through the activation of p90RSK.
Hypoxia is a key factor in the initiation of cancer cell invasion in
solid tumors [42]. To avoid cellular acidosis, hypoxia upregulates
genes involved in pHi homeostasis such as CAIX and MCTs [43].
Yang et al. have recently reported that, NHE-1 activity and
expression were increased by hypoxia in HepG2 cells [44]. NHE-1
contains a putative Hypoxia Response Element (HRE) in its
promoter and has therefore been proposed to be a HIF-1-targeted
gene [34]. In this study, we showed that the activity of NHE-1, but
not its expression, was increased under hypoxia at times where we
also observed an enhancement in the generation of invadopodia.
Using shRNA-mediated HIF-1alpha depletion, we also showed
that the increase in NHE-1 activity was independent of the
transcription factor HIF-1. Although HIF-1 has been reported to
be a key effector of hypoxia for cancer cell invasion, recent studies
have provided evidence for the implication of other signaling
pathways. Hypoxia is known to regulate the activity of the kinase
mammalian target of rapamycin (mTOR), to activate the unfolded
protein response (UPR) and transcription factors such as NF-kB
and C/EBPß [45,46,47,48]. Furthermore, HIF-2, which is also
stabilized under hypoxic conditions, can interact with HREs to
upregulate gene expression [49]. Unpublished results from our
laboratory have indicated that in fibrosarcoma cells, hypoxia-
induced increase in invadopodia production occurred in cells
where HIF-1 and HIF-2 have been silenced. These findings
suggest that both HIF isoforms are not necessary for NHE-1
activation and invadopodia production triggered by hypoxia.
NHE-1 activity can be regulated through post-translational
modifications, including phosphorylation of serine residues in the
C-terminal cytoplasmic domain. Many protein kinases regulate
NHE-1 activity, including p160ROCK, NIK and p90RSK [25].
Takahashi et al. have reported that p90RSK phosphorylates
NHE-1 at Ser
703 resulting in increased activity of the exchanger in
response to PDGF [26]. Here, inhibition of p90RSK or
transfection with a dominant negative form of the kinase led to
a strong, but incomplete, loss of NHE-1 activity (Figure 5B–5C).
Similar results were observed by overexpression of a NHE-1
S703A mutant (Figure 5D), providing evidence of a direct
modulation of NHE-1 by p90RSK. In addition, our results
indicated an increase in p90RSK-dependent NHE-1 Ser
703
Figure 4. NHE-1 is involved in hypoxia-induced cell invasion.
HT-1080 cells transfected with NHE-1 shRNA or control (scrambled)
shRNA were allowed to invade collagen gels for 24 h under normoxia or
hypoxia and stained with calcein-AM. (A) Representative confocal
images showing the relative fluorescence intensity of the cells
according to the depth of migration. (B) Graph represents maximal
depth of invasion (n=3). Columns represent the mean 6 SEM indicated
by the horizontal bars. The asterisks correspond to, * p,0.01;
** p,0.001; *** p,0.0001.
doi:10.1371/journal.pone.0028851.g004
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hypoxia. This observation was consistent with previous results that
showed that p90RSK was rapidly activated by hypoxia in cardiac
myocytes [50]. Beside p90RSK, several protein kinases can
phosphorylate NHE-1 in its C-terminal tail, including
p160ROCK and NIK [25]. p160ROCK is upregulated in various
cancers and it has been shown to be involved in invadopodia
formation [51]. ROCK is activated in hypoxia through VEGF, in
a HIF-1-independent manner [52]. These data suggest that, in
addition to p90RSK, the possibility exists for further regulations of
NHE-1 activity under hypoxic conditions.
p90RSK has been associated with cell proliferation and cell
survival [53] and recent reports have shown that p90RSK is
overexpressed in human prostate and breast cancers where it is
involved in cell proliferation (breast, prostate) and PSA expression
(prostate) [54,55]. Beside the emerging role of p90 RSK in cancer
[56], few studies have investigated its implication in cell invasion
processes. In this connection, RSK was shown to enhance the
migration of melanoma cells through phosphorylation of the
cytoskeletal protein filamin-A [57]. Here, we found that inhibition
of p90RSK or the use of a dominant negative mutant partially
reduced hypoxia- and NHE-1-induced invadopodia production.
Overexpression of a NHE-1 S703A mutant also partially inhibited
hypoxia-induced invadopodia formation as compared to wild-type
gene. The question of which exact mechanisms regulate p90RSK
activation under hypoxia is currently unknown and will be the
subject of future investigations. Results presented here (Figure 5A)
and from unpublished experiments have indicated that the
EGFR/ERK/MAPK pathway, which is activated under hypoxic
conditions [58,59,60], is possibly involved in p90RSK activation.
Hypoxia induced the relocalization of NHE-1 to the plasma
membrane and its colocalization with the invadopodia marker
cortactin. These results were consistent with a recent study
indicating similar localization of NHE-1 to invadopodia in breast
cancer cells stimulated with EGF where the exchanger was
responsible for extracellular acidification and degradation of the
ECM [24]. Despite repeated observations of NHE-1 at invado-
podia, the trafficking and/or segregation mechanisms involved in
NHE-1 location to these sites remain unknown. It has been
reported that NHE-1 is present in lipid rafts microdomains, where
it interacts with caveolin-1 [61]. Lipid rafts and caveolin-1 are
required for invadopodia formation and ECM degradation by
human breast cancer cells. Src, a non-receptor tyrosine kinase
known to be activated by hypoxia, has been shown to regulate the
localization of caveolin-1 at invadopodia formation sites [62,63].
Therefore, the hypoxic regulation of caveolin-1 in lipid rafts may
represent a potential mechanism for relocalization of NHE-1 to
invadopodia.
The intrinsic ability to propagate to distant sites is the hallmark
of malignant diseases and the leading cause of cancer death.
Alterations in tumor cell metabolism are strongly associated with
metastatic potential, which has become a central issue in cancer
treatment [64]. Because of the central role of NHE-1 in pH
regulation of malignant cells, it is being considered as a potential
Figure 5. RSK-induced NHE-1 phosphorylation increases its activity in hypoxia. (A) HT-1080 cells were cultured for the indicated periods of
time under normoxic or hypoxic conditions or for 30 min under hypoxia with the addition of the MEK1/2 inhibitor PD98059 (50 mM). Representative
immunoblots showing p90RSK Ser
380 phosphorylation and NHE-1 Ser
703 phosphorylation. NHE-1 phosphorylation was revealed using antibodies
directed against the 14-3-3 binding motif, following NHE-1 immunoprecipitation. Ratios of pRSK to total RSK and pNHE-1 to total NHE-1 are shown
(n=3). (B-D) Na
+/H
+ exchange rates were measured in cells exposed to normoxia (empty bars) or hypoxia (filled bars) in (B) the presence or absence
of the p90RSK inhibitor BI-D1870 (10 mM) (n=3), or (C) cells transfected with a dominant negative p90RSK (n=3), or (D) cells transfected with WT
NHE-1 or a S703A substitution NHE-1 mutant (n=3). Columns represent the mean 6 SEM indicated by the horizontal bars. The asterisks correspond
to, ** p,0.001; *** p,0.0001.
doi:10.1371/journal.pone.0028851.g005
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at inhibiting NHE-1 in the setting of myocardial infarction have
shown disappointing efficacy with severe adverse effects [65].
Understanding the molecular mechanisms that regulate NHE-1
activity under pathological conditions is needed to develop alternative
strategies to counteract the activity of the exchanger. Our findings
identified p90RSK as a molecular link between NHE-1-induced
extracellular acidification and invadopodia formation, providing new
insights into the cooperation between hypoxia and the acidic
microenvironment during cell invasion. Selective inhibition of
p90RSK may be a promising approach to interfere with the
metastatic potential of metabolically transformed cancer cells.
Beside cancer, the development of several hypoxia-associated
diseases including pulmonary artery hypertension, myocardial
infarction and ischemic retinopathies has been linked to NHE-1
activity and cardiac-specific overexpression of a dominant negative
form of RSK has been shown to reduce cardiac ischemia-
reperfusion injury [66,67,68,69,70]. Selective inhibition of molec-
ular mechanisms leading to NHE-1 activation may therefore
represent an alternative approach to attenuate the deleterious
influence of the metabolic microenvironment in various diseases.
Materials and Methods
Antibodies and reagents
Antibodies used for IF microscopy or Western-blotting were
purchased through commercial sources. Antibodies (and theirs
dilutions) were as follows: Rabbit anti-14-3-3 binding motif, anti-
RSK and anti-phosphoRSK (Ser
380) (WB: 1/1000) were pur-
chased from Cell Signaling (Danvers, MA). Mouse anti-tubulin
(WB: 1/1000) and rabbit anti-actin (WB : 1/5000) was purchased
from Sigma-Alldrich (St-Louis, MO). Mouse anti-cortactin clone
4F11 (WB: 1/1000, IF: 1/300) was purchase from Millipore
(Billerica, MA). 49,6-diamidino-2-phenylindol dilactate (DAPI),
Texas Red-X phalloı ¨din (IF:1/200), Alexa Fluor 647-phalloı ¨din
(IF: 1/50), and all Alexa Fluor secondary antibodies (IF: 1/200)
were from Invitrogen (Eugene, OR). Goat anti-NHE1 was
purchased from Santa Cruz Biotechnology (Santa-Cruz, CA).
Mouse anti-NHE1 (WB: 1/500) was obtained from BD Biosci-
ences (San Jose, CA). Anti-human NHE1 antibody N1P1 was a
generous gift of Dr. Josette Noe ¨l (University of Montreal,
Montreal, QC). NHE-1 inhibitors, ethyl-iso-propylamiloride
(EIPA) and ConcavalinA were purchased from Sigma-Aldrich.
29,79-Bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxy-
methyl ester (BCECF, AM) was from Invitrogen. Control shRNA
and shRNA against the 59UTR region of NHE-1 were purchase
from SABiosciences (Frederick, MD). M-Methyl-D-glucamine
chloride (NMDG) was a kind gift of Dr. Eric Rousseau (University
of Sherbrooke, Sherbrooke, QC).
Cell cultures
HT-1080 fibrosarcoma cells (ATCC, Rockville, MD) were
cultured in Minimal Essential Medium (MEM; Gibco BRL,
Figure 6. Hypoxia-induced RSK activation promotes invadopodia formation. HT-1080 cells were cultured under normoxia (empty bars) or
hypoxia (filled bars). (A) Percentage of cells producing invadopodia cultured in presence or absence of BI-D1870 (n=3). (B) Quantification of
invadopodia-associated matrix degradation was performed (n=2). (C–D) Percentage of HT-1080 cells producing invadopodia in cells (C) transfected
with DN-RSK (n=3), or (D) transfected with NHE-1 WT or S703A (n=3). Columns represent the mean 6 SEM indicated by the horizontal bars. The
asterisks correspond to, * p,0.01; ** p,0.001; *** p,0.0001.
doi:10.1371/journal.pone.0028851.g006
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40 mg/mlm gentamycin (Sandoz, Montreal, QC) in a humidified
95% O2 5% CO2 atmosphere at 37uC. In the case of hypoxic
stimulations, cells were incubated at 37uC in an In vivo2 400
hypoxic workstation (Ruskinn, Les Produits Scientifiques ESBE,
Ville St-Laurent, QC) under an atmosphere of 1% O2 and 5%
CO2.
Plasmids and transfections
pECE-NHE1-GFP was a generous gift from Dr. Jacques
Pouyssegur (Institute of Developmental Biology and Cancer
Research, Nice, France). pCMV-NHE1-HA was a kind gift of
Dr. John Orlowski (McGill University, Montreal, Canada). The
plasmids pCMV-NHE1-S703A and pcDNA3.1-DN-RSK were
generously provided by Dr. Bradford Berk (Aab Cardiovascular
Institute, Rochester, NY). shRNA against NHE-1 was purchased
from SABiosciences. Transfections were performed using the
FuGENE 6 according to the manufacturer’s protocol (Roche
Diagnostics, Laval, QC). Stable transfectants were selected and
maintained in puromycin (Cedarlane) supplemented medium.
Measurement of NHE-1 activity
Intracellular pH (pHi) was measured by confocal microscopy
using a fluorescent pH-sensitive probe (BCECF), as described [61].
Briefly, cells were incubated with ‘‘Na
+ Ringer’’ solution
containing the BCECF probe (2 mM) for 20 min at 37uC. After
washing, the cells were mounted on an Olympus confocal
microscope and excited at 450 nm and 488 nm. Emitted
fluorescence was collected at 535 nm, at 30 s intervals. NHE-1
activity was determined by measuring the rate of pHi recovery
(dpHi/dt) from an acid load produced by addition of NH4Cl
(20 mM). In the case of experiments performed under hypoxic
conditions, cells were maintained under the confocal microscope
equipped with a chamber containing a gas mixture of 1% O2 and
5% CO2 at 37uC.
RNA isolation and qRT-PCR
Total cellular RNA was isolated using the TRI-Reagent protocol
(Invitrogen, Carlsbad, CA) as described [71]. Quantitative real time
PCR was performed using the QuantiTect SYBR Green PCR kit
(Qiagen) and a Rotor-Gene 3000 instrument (Corbett Research,
San Francisco, CA). Primer sequences were as follows: NHE-1
forward (59-CCAGCTCATTGCCTTCTACC-39), NHE-1 reverse
(59-TGTGTCTGTTGTAGGACCGC-39), RPLPO forward (59-
GATTACACCTTCCCACTTGC-39), RPLPO reverse (59-CCA-
AATCCCATATCCTCGTCCG-39). Each reaction was run in
duplicates and values were normalized against the RPLPO
housekeeping gene.
Immunoprecipitation and Western blotting
Cells were lysed on ice in RIPA buffer. Cell lysates were
centrifuged at 13,000 rpm at 4uC and protein concentration was
determined using the BCA reagent (Biolynx Inc, Brockville, ON).
Immunoblotting was performed as described [72]. In the case of
immunoprecipitation experiments, 350 mg of total proteins were
immunoprecipitated using an anti-NHE-1 antibody (dilution,
1:100). To detect RSK-induced NHE1 phosphorylation on
Ser
703, an anti-14-3-3 binding motif antibody, was used as
described [40].
Invadopodia assays
Invadopodia assays were performed as described [32]. Briefly,
cells were plated on Oregon Green- or Alexa Fluor 488-labeled
gelatin and invadopodia were identified by areas of matrix
degradation characterized by a loss of fluorescence. All experiments
were performed at pH 7.4, unless indicated within figure legends.
Three-dimensional invasion assays
Three-dimensional invasion assays were performed as reported
[73].
Immunofluorescence
Cells were fixed with 1% PFA for 30 min at 4uC, permeabilized
with saponin (0.05% in PBS) for 20 min, and blocked in 2% BSA
Figure 7. NHE-1 is localized at invadopodia sites. (A) Represen-
tative confocal microscopy images showing NHE-1 staining at the basal
membrane (labeled with DiI) in HT-1080 cells cultured under normoxic
or hypoxic conditions. (B) Colocalization index of NHE-1 and basal
plasma membrane (BPM) for untransfected cells or cells transfected
with WT NHE-1 or a S703A substitution NHE-1 mutant exposed to
normoxic (empty bars) or hypoxic (solid bars) conditions (n=3). (C)
Numbers of cortactin/NHE-1 clusters per cell were quantified in HT-1080
cells cultured under normoxia or hypoxia for 4 h (n=3). N, normoxia; H,
hypoxia. Columns represent the mean 6 SEM indicated by the
horizontal bars. The asterisks correspond to, * p,0.01; ** p,0.001;
*** p,0.0001.
doi:10.1371/journal.pone.0028851.g007
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primary and secondary antibodies or fluorescent phalloidin, as
indicated in the legends of the figures. Images were taken with a
FV1000 scanning Olympus confocal microscope coupled to an
inverted microscope, using a 636 oil immersion objective. To
quantitate plasma membrane-located NHE-1, the basal cell
surface layer (first layer in contact with matrix) was scanned and
NHE-1 and plasma membrane colocalization index was calculated
according to Manders et al. [74]. Actin/cortactin colocalization
and degradation areas were determined as described [32].
Statistical analysis
Paired or unpaired Student’s t-test or one-way ANOVA test was
used to assess statistical significance, which was set at p,0.05.
Supporting Information
Figure S1 NHE-1 is involved in hypoxia-induced extra-
cellular acidification and invadopodia formation in
MDA-MB 231 and B16 cells. Human MDA-MB-231 breast
cancer cells and mouse B16 melanoma cells were exposed to
normoxic (empty columns) or hypoxic (filled columns) conditions.
Na
+/H
+ exchange rates were measured in (A) MDA-MB-231 cells
and (B) B16 cells incubated in the presence or absence of the
NHE-1 inhibitor EIPA (25 mM). For invadopodia assays, cells
were incubated in the presence or absence of the NHE-1 inhibitors
EIPA (25 mM) or Zoniporide (100 nM) and the percentage of cells
forming invadopodia was determined by fluorescence microscopy
for (C) MDA-MB-231 cells and (D) B16 cells. Columns represent
the mean 6 SEM indicated by the horizontal bars. The asterisks
correspond to, * p,0.01; ** p,0.001; *** p,0.0001.
(EPS)
Figure S2 Inhibition of NHE-1 activity by EIPA reduces
invadopodia formation. HT-1080 cells exposed to normoxic
(empty columns) or hypoxic (filled columns) conditions were
cultured on Oregon Green gelatin for 10 h and stained with Texas
Red-phalloidin (actin) and DAPI (nucleus). The percentage of cells
that formed invadopodia was determined by fluorescence
microscopy. (A) Percentage of invadopodia forming cells cultured
in presence or absence of two different concentrations of the NHE-
1 activity inhibitor EIPA (n=3). (B) Number of invadopodia
formed per cell (actin-cortactin clusters) in HT-1080 cells cultured
in the presence or absence of EIPA (25 mM). Columns represent
the mean 6 SEM indicated by the horizontal bars. The asterisks
correspond to, *** P,0.0001.
(EPS)
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